Fate Therapeutics, Inc. (FATE)
1.94
+0.10
(+5.72%)
USD |
NASDAQ |
Nov 09, 16:00
1.94
0.00 (0.00%)
After-Hours: 18:15
Fate Therapeutics Gross Profit (Annual) : -6.255M for Dec. 31, 2025
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -6.255M |
| December 31, 2024 | -5.331M |
| December 31, 2023 | 45.25M |
| December 31, 2022 | 82.54M |
| December 31, 2021 | 50.00M |
| December 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| December 31, 2014 | -0.496M |
| December 31, 2013 | 0.00 |
| December 31, 2012 | 2.08M |
| December 31, 2011 | 0.498M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| AVITA Medical, Inc. | 58.82M |
| Agenus, Inc. | 103.18M |
| Amgen, Inc. | 26.01B |
| Anika Therapeutics, Inc. | 63.81M |
| BioCryst Pharmaceuticals, Inc. | 854.37M |